Product specific pages may be be permitted to prevent user comments.
Facebook may allow some pharmaceutical brand pages to disable comments after all. When Facebook revealed in May that it will no longer allow pharma marketers to prevent people from commenting on their pages after August 15, it created waves in the industry that are still rippling.
However some pages could still have comments disabled if they fulfill certain criteria. Specifically, as confirmed by Facebook, branded pages dedicated solely to a prescription drug could still disable comments after the mid-August changeover, subject to Facebook's approval.
"Our understanding is that if you have a page that has the product name and the generic name in the title and the page [content] is strictly about that product, you can submit to Facebook and they'll make the decision and might disable comments," said Jim Dayton, senior director of emerging media at Intouch Solutions, a pharma marketing agency.
"I think they're going to be much more discretionary in how and when they disable comments.... They're going to have some pretty hard and fast criteria," he said, noting he doesn't know what Facebook will base such decisions on.
In May, Facebook notified pharma marketing clients that after the August date it would no longer allow pharma brands to turn off commenting on their pages. Despite the fact that pharma brands are highly risk averse when it comes to discussions about their drugs and products in social media environments, the company said the decision was made in an effort to keep Facebook a forum for open dialogue.
Pharma firms that still want to have a Facebook presence are working to prepare for the change. Medimmune, maker of an influenza vaccine called FluMist, will be required to enable comments on its "Don't Wait Vaccinate" page on Facebook, for instance, since it is not product-specific. The company planned to meet this afternoon to discuss its plans on how to move forward with the page in light of the new rules, according to Glenn Byrd, senior director of regulatory affairs at Medimmune.
Some pharma marketers could use a workaround allowing them to moderate comments in a more controlled manner than Facebook itself enables. Intouch Solutions has developed its PharmaWall app which allows page admins to moderate comments. The tool places user comments in a moderation queue subject to approval, revision or deletion.
According to Dayton, using Facebook's moderation system alone, marketers are only able to control comments when keywords they've submitted to the system automatically trigger it to put a comment aside for closer inspection. "It's basically a really good profanity filter," said Dayton of Facebook's moderation system.
Intouch is charging a licensing and setup fee for use of the app.
Kate Kaye was Managing Editor at ClickZ News until October 2012. As a daily reporter and editor for the original news source, she covered beats including digital political campaigns and government regulation of the online ad industry. Kate is the author of Campaign '08: A Turning Point for Digital Media, the only book focused on the paid digital media efforts of the 2008 presidential campaigns. Kate created ClickZ's Politics & Advocacy section, and is the primary contributor to the one-of-a-kind section. She began reporting on the interactive ad industry in 1999 and has spoken at several events and in interviews for television, radio, print, and digital media outlets. You can follow Kate on Twitter at @LowbrowKate.
2015 Holiday Email Guide
The holidays are just around the corner. Download this whitepaper to find out how to create successful holiday email campaigns that drive engagement and revenue.
Three Ways to Make Your Big Data More Valuable
Big data holds a lot of promise for marketers, but are marketers ready to make the most of it to drive better business decisions and improve ROI? This study looks at the hidden challenges modern marketers face when trying to put big data to use.
December 2, 2015
1pm ET/ 10am PT
Wednesday, December 9, 2015
5pm HKT / 5am ET